Projects

General and Integrated Ultrafast Sintering for Nanostructured Films (GENIUS)

        Reference: 2025 LLAV 00168 Duration: 16/09/2025 – 15/03/2026 GENIUS aims to extend the capabilities of a novel ultrafast chemical sintering method for noble metal nanoparticles addressing critical gaps, exploring scaling up of the process and validating its compatibility with commercially available metal nanoparticle...

Development of a non-invasive IVD for endometrial cancer screening on high-risk populations (ScreenEC)

Reference: CPP2022-009817 Duration: 01/10/2023 – 30/09/2026 Early and accurate detection of endometrial cancer (EC) is an important factor in EC survival. EC is the 6th most common cancer and the 4th leading cause of cancer deaths in women. By 2040 the number of new EC cases diagnosed worldwide is expected to increase by 46%...

Knowledge and skills transfer for the applications of nanotechnology in biosensors for foodborne pathogens (Know4Nano)

          Grant Agreement No. 101159710 Duration: 01/10/2024 – 30/09/2027 The Know4Nano project will bring together BioSens Institute and three leading EU research institutions, whose complementary expertise in the field of BnT will be leveraged to develop cutting-edge biosensing platforms for practical applications...

Twinning to boost the scientific and innovation capacity of the Universiteti i Tiranes to develop sustainable nanosensors for water pollution detection (SUSNANO)

      Grant Agreement No. 101059266 Duration: 01/09/2022 – 28/02/2026 SUSNANO is a Horizon Europe Twinning project with the overall aim to boost the scientific excellence and innovation capacity in sustainable nanosensors for water pollution detection of Universiteti i Tiranes (UT) and its high-quality Twinning partners....

Dispositivos de punto de atención basados en nanomateriales totalmente integrados para aplicaciones de atención médica / Fully integrated nanomaterial-based point-of-care devices for health care applications (FULLPOC)

Reference: PID2021-124795NB-I00 Funded by: funded by MICIU/AEI/10.13039/501100011033 and by “ERDF/EU” Period: 01/01/2022 – 31/12/2024 Summary: The value of diagnostic platforms has become widely recognised during the covid-19 pandemic. There are many diagnostic tests, such as PCR and ELISA that allow the diagnosis of a...

Graphene Bio-Platform for point-of-care early detection and monitoring of Alzheimer’s Disease (2D-Biopad)

     Grant Agreement No.101120706 October 2023-September 2027 With about 6 million euros over four years and the participation of 11 partners led by CATRIN – RCPTM, 2D-BioPAD will exploit nanotechnology and the unique properties of graphene, as well as the power of artificial intelligence, to provide an innovative technological...

Nano-Monitoring of Cancer Immunotherapy Efficiency: The Graphene Lateral Electrophoretic Bioassay platform (GLEBIOASSAY)

Reference: AC21_2/00044 Funded by: Instituto de Salud Carlos III and European Union Next Generation EU / PRTR Period: 01/01/2022 – 30/06/2025 Partners: Fundació Privada per a la Recerca i la Docència Sant Joan de Déu (FSJD) (Spain), Palacký University Olomouc (UP) (Czech Republic) Summary: GLEBioassay aims to develop a...

Polymerase Amplification combined into a Paper-based electrochemical lateral flow arraY for antimicrobial Resistance qUantification (PAPYRUs))

Reference: PLEC2021-007972 Funded by: MCIN / AEI / 10.13039/501100011033 and European Union Next Generation EU / PRTR Period: 01/11/2021 – 30/06/2025 Partners: Fundación Pública Andaluza para la Gestió de la Investigación en Salud de Sevilla (Spain), Paperdrop Dx (Spain) Summary: In the PAPYRUs project we aim to prototype...

Emerging Printed Electronics Research Infrastructure (EMERGE)

Reference: 101008701 Funded by: European Commission Period: 01/07/2021 – 31/12/2025 https://emerge-infrastructure.eu/   Partners: : UNINOVA-INSTITUTO DE DESENVOLVIMENTO DE NOVAS TECNOLOGIAS-ASSOCIACAO (Portugal), ELLINIKO MESOGEIAKO PANEPISTIMIO (Greece), POLITECHNIKA WARSZAWSKA (Poland), FORSCHUNGSZENTRUM JULICH GMBH (Germany),...

Real-time sensing of diagnostically relevant biomarkers in urine for the Monitoring of Acute Kidney Injury (2) – (MAKI-2)

Funded by: BIST Period: 01/01/2022 – 31/12/2022   Partners: Fundació Institut Català de Nanociència i Nanotecnologia (ICN2) and Institut Català d’Investigació Química (ICIQ) Summary: The second phase of MAKI-2 will allow us to continue improving the binding studies in the solid-liquid interface and to test the...